Francesc Marco
Francesc Marco
Cap de Secció Bacteriologia
Verified email at
Cited by
Cited by
Influence of Vancomycin Minimum Inhibitory Concentration on the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
A Soriano, F Marco, JA Martínez, E Pisos, M Almela, VP Dimova, D Alamo, ...
Clinical Infectious Diseases 46 (2), 193-200, 2008
Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double‐blind, placebo‐controlled trial
P Ginés, A Rimola, R Planas, V Vargas, F Marco, M Almela, M Forne, ...
Hepatology 12 (4), 716-724, 1990
Addition of a macrolide to a β-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia
JA Martínez, JP Horcajada, M Almela, F Marco, A Soriano, MA Marco, ...
Clinical Infectious Diseases 36 (4), 389-395, 2003
Severe community-acquired pneumonia: risk factors and follow-up epidemiology
M Ruiz, S Ewig, A Torres, F Arancibia, F Marco, J Mensa, M Sanchez, ...
American journal of respiratory and critical care medicine 160 (3), 923-929, 1999
Residual pituitary function after brain injury-induced hypopituitarism: a prospective 12-month study
G Aimaretti, MR Ambrosio, C Di Somma, M Gasperi, S Cannavo, ...
The Journal of Clinical Endocrinology & Metabolism 90 (11), 6085-6092, 2005
Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis
M Navasa, A Follo, JM Llovet, G Clemente, V Vargas, A Rimola, F Marco, ...
Gastroenterology 111 (4), 1011-1017, 1996
Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment: analysis of 189 episodes
F Vidal, J Mensa, M Almela, JA Martínez, F Marco, C Casals, JM Gatell, ...
Archives of Internal Medicine 156 (18), 2121-2126, 1996
Pathogenic Significance of Methicillin Resistance for Patients with Staphylococcus aureus Bacteremia
A Soriano, JA Martinez, J Mensa, F Marco, M Almela, A Moreno-Martinez, ...
Clinical infectious diseases 30 (2), 368-373, 2000
Safety and efficacy of the subclavian approach for transcatheter aortic valve implantation with the CoreValve revalving system
AS Petronio, M De Carlo, F Bedogni, A Marzocchi, S Klugmann, ...
Circulation: Cardiovascular Interventions 3 (4), 359-366, 2010
In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi
MA Pfaller, F Marco, SA Messer, RN Jones
Diagnostic microbiology and infectious disease 30 (4), 251-255, 1998
Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs.
J Vila, J Ruiz, F Marco, A Barcelo, P Goni, E Giralt, TJ De Anta
Antimicrobial agents and chemotherapy 38 (10), 2477-2479, 1994
Pneumonia acquired in the community through drug-resistant Streptococcus pneumoniae
S Ewig, M Ruiz, A Torres, F Marco, JA Martinez, M Sanchez, J Mensa
American journal of respiratory and critical care medicine 159 (6), 1835-1842, 1999
Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome
M Ortega, F Marco, A Soriano, M Almela, JA Martínez, A Munoz, J Mensa
Journal of antimicrobial chemotherapy 63 (3), 568-574, 2009
Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study
A Rimola, JM Salmerón, G Clemente, L Rodrigo, A Obrador, ML Miranda, ...
Hepatology 21 (3), 674-679, 1995
Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone
J Gavalda, O Len, JM Miró, P Munoz, M Montejo, A Alarcón, ...
Annals of internal medicine 146 (8), 574-579, 2007
Staphylococcus lugdunensis infective endocarditis: description of 10 cases and analysis of native valve, prosthetic valve, and pacemaker lead endocarditis clinical profiles
I Anguera, A Del Rio, JM Miro, X Matinez-Lacasa, F Marco, JR Guma, ...
Heart 91 (2), e10-e10, 2005
In vitro antimicrobial production of beta-lactamases, aminoglycoside-modifying enzymes, and chloramphenicol acetyltransferase by and susceptibility of clinical isolates of …
J Vila, A Marcos, F Marco, S Abdalla, Y Vergara, R Reig, R Gomez-Lus, ...
Antimicrobial agents and chemotherapy 37 (1), 138-141, 1993
Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis
VH Chu, CW Woods, JM Miro, B Hoen, CH Cabell, PA Pappas, ...
Clinical infectious diseases 46 (2), 232-242, 2008
Candida species bloodstream infection: epidemiology and outcome in a single institution from 1991 to 2008
M Ortega, F Marco, A Soriano, M Almela, JA Martínez, J López, C Pitart, ...
Journal of hospital infection 77 (2), 157-161, 2011
Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey
J Pemán, E Cantón, G Quindós, E Eraso, J Alcoba, J Guinea, P Merino, ...
Journal of antimicrobial chemotherapy 67 (5), 1181-1187, 2012
The system can't perform the operation now. Try again later.
Articles 1–20